# Evaluation of RBS2418 in Patients With Advanced, Metastatic, and Progressive Colorectal Cancer

Source: https://onco.cc/trials/nct06824064/  
OnCo record `nct06824064` (Trial). Data CC BY-NC 4.0, attribute "Data from OnCo (onco.cc)"; commercial use needs a licence.

## TL;DR

A phase 2 trial of RBS2418 in colorectal cancer, run by Riboscience, LLC., now recruiting.

## Summary

Evaluation of RBS2418 in Patients With Advanced, Metastatic, and Progressive Colorectal Cancer is a phase 2 interventional study registered as NCT06824064 by Riboscience, LLC., with 150 participants planned, started 2025-01-17 and due to reach its primary completion in 2027-12. Interventions recorded: RBS2418 and Placebo.

## Fields

- Kind: Trial
- Status: recruiting
- Last checked: 2026-09-16
- Tags: pipeline; ctgov-ingest
- Registry id: NCT06824064
- Phase: 2
- Setting: A Randomized, Double-Blind, Placebo-Controlled, Phase 2a Study of RBS2418 Plus Best Supportive Care (BSC) in Subjects With Advanced, Metastatic, and Progressive Colorectal Cancer
- Sponsor: Riboscience, LLC.
- Enrolled: 150

## Sources

- ClinicalTrials.gov NCT06824064: https://clinicaltrials.gov/study/NCT06824064

## Connected records

- cancers: [Colorectal cancer](https://onco.cc/cancers/colorectal/)

---
JSON: https://onco.cc/api/v1/entities/nct06824064.json